The Physical Implications of Stigma in People Living With HIV
32m
·
Keeping Current
·
What are the clinical and cellular effects of stigma in your patients living with HIV?
Credit available for this activity expires: 3/13/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000379?ecd=bdc_podcast_libsyn_mscpedu
The episode The Physical Implications of Stigma in People Living With HIV from the podcast Keeping Current has a duration of
32:08. It was first published
More episodes from Keeping Current
Evolving Perspectives on HR-Positive Metastatic Breast Cancer: Current Understanding and New Insights
Are you up to date on the latest developments in hormone receptor-positive metastatic breast cancer? Listen to our expert panel to find out more!
Credit available for this activity expires: 05/20/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000713?ecd=bdc_podcast_libsyn_mscpedu
SGLT2 Inhibitors in the Post-Myocardial Infarction Population: Answering the Last Unanswered Question
Are you ready to answer the last remaining question in sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy for heart failure (HF)?
Credit available for this activity expires: 5/13/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000749?ecd=bdc_podcast_libsyn_mscpedu
Personalizing Care for Breast Cancer: The Precision Medicine Approach
Do you really know the optimal biomarker tests for personalizing breast cancer treatment? Are some just unnecessary? Find out from the experts!
Credit available for this activity expires: 4/30/2025
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000564?ecd=bdc_podcast_libsyn_mscpedu
A Roadmap to Relief: Managing Agitation in Dementia Associated With Alzheimer's Disease
Do you know the symptoms that affect more than 80% of people with Alzheimer's disease in some countries?
Credit available for this activity expires: 04/29/2025
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000723?ecd=bdc_podcast_libsyn_mscpedu
Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow
Are you selecting the right Bruton tyrosine kinase (BTK) inhibitor for your patients with chronic lymphocytic leukemia (CLL)? Experts discuss the key differentiators and upcoming developments in the field.
Credit available for this activity expires: 04/26/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000717?ecd=bdc_podcast_libsyn_mscpedu